Get the Stockscreener App
0.6883
0.59%
-0.0022
Harvard Bioscience Inc stock is traded at $0.6883, with a volume of 39,103.
It is down -0.59% in the last 24 hours and down -9.41% over the past month.
Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, specialized products and services that enable fundamental research, pharmaceutical and therapy discovery, bioproduction, and pre-clinical testing for drug development. Its primary focus is scientific instruments used to advance life sciences and research. With operations in North America, Europe and china it sells through a combination of direct and distribution channels to customers around the world. The product brands of the company include Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, and Panlab. The majority of its revenue comes from the United States.
See More
Previous Close:
$0.6905
Open:
$0.6977
24h Volume:
39,103
Relative Volume:
0.01
Market Cap:
$30.43M
Revenue:
$106.79M
Net Income/Loss:
$-8.73M
P/E Ratio:
-3.4415
EPS:
-0.2
Net Cash Flow:
$10.81M
1W Performance:
+2.63%
1M Performance:
-9.41%
6M Performance:
+54.94%
1Y Performance:
-68.07%
1-Day Range:
$0.68
$0.698
1-Week Range:
$0.642
$0.71
52-Week Range:
$0.2813
$2.19
Harvard Bioscience Inc Stock (HBIO) Company Profile
Name
Harvard Bioscience Inc
Sector
Industry
Phone
(508) 893-8999
Address
84 OCTOBER HILL RD, HOLLISTON, MA
Compare HBIO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HBIO
Harvard Bioscience Inc
|
0.6825 | 30.78M | 106.79M | -8.73M | 10.81M | -0.20 |
|
ISRG
Intuitive Surgical Inc
|
595.57 | 210.16B | 9.61B | 2.77B | 2.27B | 7.555 |
|
BDX
Becton Dickinson Co
|
205.57 | 58.51B | 21.84B | 1.68B | 2.67B | 5.8293 |
|
ALC
Alcon Inc
|
80.99 | 40.19B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
RMD
Resmed Inc
|
247.51 | 36.37B | 5.26B | 1.44B | 1.76B | 9.7713 |
|
MDLN
Medline Inc
|
40.45 | 31.30B | 27.43B | 1.27B | 1.01B | 1.5829 |
Harvard Bioscience Inc Stock (HBIO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-09-25 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Mar-10-23 | Upgrade | The Benchmark Company | Speculative Buy → Buy |
| Jan-07-21 | Upgrade | The Benchmark Company | Speculative Buy → Buy |
| Dec-09-20 | Initiated | Northland Capital | Outperform |
| Nov-10-20 | Initiated | KeyBanc Capital Markets | Overweight |
| Jul-08-19 | Downgrade | Janney | Buy → Neutral |
| Jan-24-18 | Reiterated | Janney | Buy |
| Jan-23-18 | Reiterated | The Benchmark Company | Buy |
| Nov-17-16 | Initiated | Singular Research | Buy |
| Jul-28-15 | Initiated | The Benchmark Company | Buy |
View All
Harvard Bioscience Inc Stock (HBIO) Latest News
Is Harvard Bioscience Inc. (HBI) stock among top earnings playsGrowth Stock Opportunities & Exceptional Return Capital - bollywoodhelpline.com
Can Harvard Bioscience Inc. stock outperform in 2025 bull marketEarnings Growth Summary & Weekly Watchlist for Consistent Profits - Улправда
Should I hold or sell Harvard Bioscience Inc. stock in 2025M&A Rumor & Safe Capital Growth Plans - Улправда
Is Harvard Bioscience Inc. stock gaining market shareJuly 2025 Reactions & Reliable Momentum Entry Alerts - Улправда
Dow Update: How Harvard Bioscience Inc. (HBI) stock responds to bond market2025 Growth vs Value & Step-by-Step Swing Trade Plans - DonanımHaber
How strong is Harvard Bioscience Inc. stock revenue growthJuly 2025 Review & Risk Controlled Daily Plans - DonanımHaber
How Harvard Bioscience Inc. (HBI) stock responds to bond marketJuly 2025 Action & Long Hold Capital Preservation Tips - DonanımHaber
Can Harvard Bioscience Inc. stock resist sector downturns2025 Price Momentum & Real-Time Volume Analysis - DonanımHaber
How Harvard Bioscience Inc. stock trades during market volatilityJuly 2025 News Drivers & AI Based Buy and Sell Signals - Улправда
Is Harvard Bioscience Inc. stock a buy on dipsJuly 2025 Closing Moves & Weekly Market Pulse Updates - Улправда
Harvard Bioscience secures $40 million credit facility from BroadOak By Investing.com - Investing.com South Africa
Harvard Bioscience Secures $40M Loan Agreement - The Globe and Mail
Harvard Bioscience secures $40M loan agreement - MSN
Harvard Bioscience, Inc. Appoints Bill Snider as Member of Class III of the Board and as Member of Compensation Committee, Effective December 17, 2025 - marketscreener.com
Harvard Bioscience Announces the Successful Completion of Debt Refinancing with Comprehensive Growth Financing Package - marketscreener.com
Harvard Bioscience, Inc. announced that it expects to receive $40 million in funding from BroadOak Capital Partners, LLC - marketscreener.com
Harvard Bioscience announces the successful completion of debt refinancing - marketscreener.com
Harvard Bioscience secures $40 million credit facility from BroadOak - Investing.com
Harvard Bioscience enters loan agreement with some lenders - marketscreener.com
Harvard Bioscience Appoints William A. Snider to Board of Directors - TradingView — Track All Markets
Harvard Bioscience (NASDAQ: HBIO) signs loan deal and names director to board - Stock Titan
Harvard Bioscience Announces the Successful Completion of - GlobeNewswire
Harvard Bioscience Earnings Notes - Trefis
What drives Harvard Bioscience Inc HBI stock priceIndustrial Stocks Review & High Profit Trading Plans - earlytimes.in
Its Stock Has Paid Off Big Time For Harvard Bioscience Inc - setenews.com
Harvard Bioscience Engages in Credit Agreement Discussions - TipRanks
Is Harvard Bioscience Inc. (HBI) stock cheap vs fundamentalsJuly 2025 Pullbacks & Low Risk High Reward Ideas - Newser
Can Harvard Bioscience Inc. stock continue upward trendJuly 2025 Market Mood & Low Risk Investment Opportunities - Newser
Can Harvard Bioscience Inc. (HBI) stock stage a strong rebound this quarterJuly 2025 Highlights & High Accuracy Investment Entry Signals - Newser
Research Analysts’ Weekly Ratings Updates for Harvard Bioscience (HBIO) - Defense World
Further Upside For Harvard Bioscience, Inc. (NASDAQ:HBIO) Shares Could Introduce Price Risks After 27% Bounce - simplywall.st
Will Harvard Bioscience Inc. (HBI) stock sustain bullish trend into 2025 - Newser
How Harvard Bioscience Inc. stock benefits from tech adoptionJuly 2025 Setups & Entry and Exit Point Strategies - Newser
What Wall Street predicts for Harvard Bioscience Inc. stock priceWeekly Trade Review & Verified Technical Signals - Newser
It is Poised to be a Bull Market for Harvard Bioscience Inc (HBIO) - Setenews
Holdings of Harvard Bioscience Inc (HBIO) are aligned with the stars - Setenews
Is Harvard Bioscience Inc. (HBI) stock worth buying before Fed actionQuarterly Profit Report & Weekly High Conviction Ideas - newser.com
Key resistance and support levels for Harvard Bioscience Inc.Quarterly Profit Report & Weekly Market Pulse Updates - newser.com
How Harvard Bioscience Inc. (HBI) stock compares with tech leadersPortfolio Value Summary & Weekly Stock Breakout Alerts - newser.com
Harvard Bioscience Inc Stock (HBIO) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.50%
0.03%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):